Angiogenesis	O
associated	O
with	O
visceral	B-Tissue
and	O
subcutaneous	B-Tissue
adipose	I-Tissue
tissue	I-Tissue
in	O
severe	O
human	O
obesity	O
.	O

OBJECTIVE	O
:	O
The	O
expansion	O
of	O
adipose	B-Tissue
tissue	I-Tissue
is	O
linked	O
to	O
the	O
development	O
of	O
its	O
vasculature	B-Multi-tissue_structure
.	O

However	O
,	O
the	O
regulation	O
of	O
adipose	B-Tissue
tissue	I-Tissue
angiogenesis	O
in	O
humans	O
has	O
not	O
been	O
extensively	O
studied	O
.	O

Our	O
aim	O
was	O
to	O
compare	O
the	O
angiogenesis	O
associated	O
with	O
subcutaneous	B-Tissue
adipose	I-Tissue
tissue	I-Tissue
(	O
SAT	B-Tissue
)	O
and	O
visceral	B-Tissue
adipose	I-Tissue
tissue	I-Tissue
(	O
VAT	B-Tissue
)	O
from	O
the	O
same	O
obese	O
patients	O
in	O
an	O
in	O
vivo	O
model	O
.	O

RESEARCH	O
DESIGN	O
AND	O
METHODS	O
:	O
Adipose	B-Tissue
tissue	I-Tissue
samples	I-Tissue
from	O
visceral	B-Tissue
(	O
VAT	B-Tissue
)	O
and	O
subcutaneous	B-Tissue
(	I-Tissue
SAT	I-Tissue
)	I-Tissue
sites	I-Tissue
,	O
obtained	O
from	O
36	O
obese	O
patients	O
(	O
mean	O
BMI	O
46	O
.	O
5	O
kg	O
/	O
m	O
(	O
2	O
)	O
)	O
during	O
bariatric	O
surgery	O
,	O
were	O
layered	O
on	O
chick	O
chorioallantoic	B-Multi-tissue_structure
membrane	I-Multi-tissue_structure
(	O
CAM	B-Multi-tissue_structure
)	O
.	O

RESULTS	O
:	O
Both	O
SAT	B-Tissue
and	O
VAT	B-Tissue
expressed	O
angiogenic	O
factors	O
without	O
significant	O
difference	O
for	O
vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
expression	O
.	O

Adipose	B-Tissue
tissue	I-Tissue
layered	O
on	O
CAM	B-Multi-tissue_structure
stimulated	O
angiogenesis	O
.	O

Angiogenic	O
stimulation	O
was	O
macroscopically	O
detectable	O
,	O
with	O
engulfment	O
of	O
the	O
samples	B-Tissue
,	O
in	O
39	O
%	O
and	O
was	O
evidenced	O
by	O
angiography	O
in	O
59	O
%	O
of	O
the	O
samples	B-Tissue
.	O

A	O
connection	O
between	O
CAM	B-Multi-tissue_structure
and	O
adipose	B-Tissue
tissue	I-Tissue
vessels	I-Tissue
was	O
evidenced	O
by	O
immunohistochemistry	O
,	O
with	O
recruitment	O
of	O
both	O
avian	O
and	O
human	O
endothelial	B-Cell
cells	I-Cell
.	O

The	O
angiogenic	O
potency	O
of	O
adipose	B-Tissue
tissue	I-Tissue
was	O
not	O
related	O
to	O
its	O
localization	O
(	O
with	O
an	O
angiogenic	O
stimulation	O
in	O
60	O
%	O
of	O
SAT	B-Tissue
samples	I-Tissue
and	O
61	O
%	O
of	O
VAT	B-Tissue
samples	I-Tissue
)	O
or	O
to	O
adipocyte	B-Cell
size	O
or	O
inflammatory	O
infiltrate	O
assessed	O
in	O
adipose	B-Tissue
samples	I-Tissue
before	O
the	O
graft	B-Tissue
on	O
CAM	B-Multi-tissue_structure
.	O

Stimulation	O
of	O
angiogenesis	O
by	O
adipose	B-Tissue
tissue	I-Tissue
was	O
nearly	O
abolished	O
by	O
bevacizumab	O
,	O
which	O
specifically	O
targets	O
human	O
VEGF	O
.	O

CONCLUSIONS	O
:	O
We	O
have	O
established	O
a	O
model	O
to	O
study	O
the	O
regulation	O
of	O
angiogenesis	O
by	O
human	O
adipose	B-Tissue
tissue	I-Tissue
.	O

This	O
model	O
highlighted	O
the	O
role	O
of	O
VEGF	O
in	O
angiogenesis	O
in	O
both	O
SAT	B-Tissue
and	O
VAT	B-Tissue
.	O

